Tiziana Life Sciences (TLSA) Long-Term Investments (2022 - 2025)

Tiziana Life Sciences (TLSA) has reported Long-Term Investments for 4 consecutive years, with $3.7 million the latest figure, recorded in Q2 2025.

• Quarterly Long-Term Investments rose 25.67% year-over-year to $3.7 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $3.7 million (up 25.67% YoY) and the FY2024 annual result came in at $3.6 million, down 21.19% from the prior year.
• Long-Term Investments improved to $3.7 million in Q2 2025 per TLSA's latest filing, from $3.6 million in the prior quarter.
• Over the last five years, Long-Term Investments for TLSA reached as high as $3.7 million in Q2 2025 and fell as low as -$1.0 million in Q4 2023.
• A 4-year average of $2.2 million and a median of $2.7 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2023 — Long-Term Investments tumbled 155.37% — and 2024, when it soared 458.9%.
• Year by year, Long-Term Investments stood at $1.8 million in 2022, then tumbled by 155.37% to -$1.0 million in 2023, then surged by 458.9% to $3.6 million in 2024, then rose by 3.96% to $3.7 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $3.7 million, $3.6 million, and $3.0 million for Q2 2025, Q4 2024, and Q2 2024 respectively.